C-reactive protein-triglyceride-glucose index

There are 91 papers on C-reactive protein-triglyceride-glucose index in aging research: 89 observational studies in people, 2 reviews. The newest story, Nov 13, 2026: “Blood and body-size scores linked to cardiovascular risk”.

Biomarker

91 papers study it11 more mention it119 findings

21 new papers in 30 daysSee all 102 papers on C-reactive protein-triglyceride-glucose index

“CTI mediated approximately 42-54% of the associations between sustained or progressive obesity trajectories and CRMM comorbidity outcomes.”
Life-course body size trajectories and the progression of cardio-renal-metabolic multimorbidity: a prospective UK biobank studyNutrition & metabolism2026doi:10.1186/s12986-026-01148-7
  • Humans89

Effects

8

Self-reported stroke

no changein humans1OR 1.17

1 study
  1. C-reactive protein-triglyceride-glucose index was not clearly linked with self-reported stroke in humans (fully adjusted Model 3) (OR 1.17, 95% CI 0.93–1.48).

    “In Model 3, continuous CTI was not significantly associated with self-reported stroke”

    Humansfully adjusted Model 3n = 6,053

    Association of the C-reactive protein-triglyceride glucose index with self-reported stroke among U.S. adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey

    Medicine

More on Self-reported stroke

Frailty progression

upin humans1

1 study
  1. C-reactive protein-triglyceride-glucose index is linked with higher frailty progression in humans (compared with the low trajectory) (β = 0.263, 95% CI 0.074-0.451).

    “linear mixed-effects modeling revealed accelerated deficit accumulation over time in this high-risk group (Chinese cohort: β = 0.263, 95% confidence interval 0.074-0.451”

    Humanscompared with the low trajectoryn = 3,947

    High metabolic inflammation trajectories predict faster frailty progression in older adults

    Maturitas

Asthma prevalence

no changein humans1OR 1.07

1 study
  1. C-reactive protein-triglyceride-glucose index was not clearly linked with asthma prevalence in humans (Fully adjusted model) (OR 1.07, 95% CI 0.99–1.16).

    “The fully adjusted model revealed no significant association between CTI and asthma prevalence”

    HumansFully adjusted modeln = 13,972

    Association Between C-Reactive Protein-Triglyceride Glucose Index and All-Cause Mortality and Exacerbation in Adult Asthma: NHANES, 1999-2010 and 2015-2018

    Allergy, asthma & immunology research

Cardiovascular disease

no changein humans1OR 1.08

1 study
  1. C-reactive protein-triglyceride-glucose index was not clearly linked with cardiovascular disease in humans (UK Biobank cohort, full adjustment) (OR = 1.08, 95% CI: 0.95-1.22).

    “In the UK Biobank cohort, the CTI-CVD association attenuated progressively and became non-significant after full adjustment (OR = 1.08, 95% CI: 0.95-1.22, p = 0.261; AUC = 0.649).”

    HumansUK Biobank cohort, full adjustment

    Association of the C-reactive protein-triglyceride-glucose index with the risk of incident cardiovascular disease in rectal cancer survivors

    Frontiers in cardiovascular medicine

More on Cardiovascular disease

Cardio-renal-metabolic multimorbidity

mediatesin humans1

1 study
  1. C-reactive protein-triglyceride-glucose index is linked with cardio-renal-metabolic multimorbidity in humans (sustained or progressive obesity trajectories) (approximately 42-54% of the associations).

    “CTI mediated approximately 42-54% of the associations between sustained or progressive obesity trajectories and CRMM comorbidity outcomes.”

    Humanssustained or progressive obesity trajectories

    Life-course body size trajectories and the progression of cardio-renal-metabolic multimorbidity: a prospective UK biobank study

    Nutrition & metabolism

More on Cardio-renal-metabolic multimorbidity

Estimated glomerular filtration rate

downin humans1

1 study
  1. C-reactive protein-triglyceride-glucose index is linked with lower estimated glomerular filtration rate in humans.

    “inverse associations observed with estimated glomerular filtration rate”

    Humans

    Association of C-Reactive Protein-Triglyceride Glucose Index With Chronic Kidney Disease and Reduction of Renal Function

    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

More on Estimated glomerular filtration rate

Hypertension

mediatesin humans1

1 study
  1. C-reactive protein-triglyceride-glucose index is linked with hypertension in humans (association between anthropometric indices and hypertension).

    “Mediation analysis revealed that CTI significantly mediated the association between anthropometric indices and hypertension.”

    Humansassociation between anthropometric indices and hypertension

    Joint associations of anthropometric indices and C-reactive protein-triglyceride-glucose index with incident hypertension: a stratified analysis by blood pressure level from the CHARLS, 2011-2020

    Cardiovascular diabetology

More on Hypertension

Mortality

no changein humans1HR 0.87

1 study
  1. C-reactive protein-triglyceride-glucose index was not clearly linked with mortality in humans (CTI < 4.16) (HR 0.87, 95% CI: 0.74-1.03).

    “Below this value, no significant association with all-cause mortality was found (hazard ratio - HR 0.87, 95% CI: 0.74-1.03)”

    HumansCTI < 4.16femalesn = 5,582

    Association of C-reactive protein-triglyceride-glucose index with all-cause and cardiovascular mortality in postmenopausal women

    Przeglad menopauzalny = Menopause review

Associations

45

Mortality

upin humans16no changein humans1HR 0.99–3.48

16 studies
  1. C-reactive protein-triglyceride-glucose index is associated with mortality in humans (cardiometabolic multimorbidity) (Per 1-SD increase: HR 1.17, 95% CI 1.07–1.29; highest versus lowest quartile: HR 1.75, 95% CI 1.30–2.37).

    “Per 1-SD increase in CTI corresponded to a 17% higher mortality risk (HR=1.17, 95% CI 1.07–1.29)”

    Humanscardiometabolic multimorbidity365 daysn = 7,220

    Association between C-reactive protein-triglyceride-glucose index and one-year all-cause mortality in patients with cardiometabolic multimorbidity

    Frontiers in cardiovascular medicine

  2. C-reactive protein-triglyceride-glucose index is associated with mortality in humans (Patients with chronic kidney disease and coronary artery disease; adjusted analysis) (HR 1.43, 95% CI 1.24–1.65).

    “Adjusted models showed elevated composite indices linked to higher mortality (e.g., CTI HR 1.43 [95% CI 1.24–1.65] for all-cause; HR 1.32 [1.06–1.64] for CVD).”

    HumansPatients with chronic kidney disease and coronary artery disease; adjusted analysisMedian follow-up of 63 monthsn = 1,353

    Prognostic stratification with composite insulin resistance inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses

    ESC Congress 2026 abstract

  3. C-reactive protein-triglyceride-glucose index is associated with mortality in humans (Postmenopausal women in NHANES with CTI below 5.43; per-unit CTI increase) (HR 0.99 per unit below CTI 5.43, 95% CI 0.89-1.10; P = 0.87).

    “below, HR = 0.99 (95% CI 0.89-1.10; P = 0.87).”

    HumansPostmenopausal women in NHANES with CTI below 5.43; per-unit CTI increaseMedian 11.9 yearsfemales

    Higher blood-based index linked to death after menopause

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

  4. C-reactive protein-triglyceride-glucose index predicts mortality in humans (Postmenopausal women; fully adjusted association per 1-unit CTI increase) (HR 1.28 per 1-unit increase, 95% CI 1.20-1.35).

    “Each 1-unit CTI increase carried a 28% higher mortality hazard after full adjustment (hazard ratio [HR] 1.28; 95% confidence interval [CI] 1.20-1.35; P < 0.001).”

    HumansPostmenopausal women; fully adjusted association per 1-unit CTI increasefemales

    Higher blood-based index linked to death after menopause

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

  5. C-reactive protein-triglyceride-glucose index is associated with mortality in humans (Adults with asthma; fully adjusted model) (HR 1.43, 95% CI 1.12–1.81).

    “but showed a strong association with all-cause mortality (hazard ratio [HR], 1.43; 95% CI, 1.12-1.81; P = 0.004).”

    HumansAdults with asthma; fully adjusted modeln = 1,832

    Association Between C-Reactive Protein-Triglyceride Glucose Index and All-Cause Mortality and Exacerbation in Adult Asthma: NHANES, 1999-2010 and 2015-2018

    Allergy, asthma & immunology research

  6. C-reactive protein-triglyceride-glucose index predicts mortality in humans (per SD increase) (35% higher risk (95% CI: 1.24-1.48)).

    “Each SD increase in CTI was associated with a 35% higher risk of all-cause mortality (95% CI: 1.24-1.48)”

    Humansper SD increase152 months median follow-upn = 8,314

    Association Between C-Reactive Protein-Triglyceride Glucose Index and All-Cause and Cardiovascular Mortality Across Cardiovascular-Kidney-Metabolic Syndrome Stages 0-4

    International journal of endocrinology

  7. C-reactive protein-triglyceride-glucose index is linked with a higher risk of mortality in NHANES (HR=1.19, 95% CI:1.14-1.25).

    “In NHANES, higher CTI was associated with all-cause mortality (HR=1.19, 95% CI:1.14-1.25)”

    Humansin NHANES

    Association between C-Reactive Protein–Triglyceride–Glucose Index and New-Onset Chronic Disease Incidence and Mortality: Evidence from Multinational Cohorts

    ADA Scientific Sessions 2026 abstract

  8. C-reactive protein-triglyceride-glucose index is linked with a higher risk of mortality in humans (high vs low CTI group) (HR: 1.25, 95% CI 1.20–1.29).

    “the high-CTI group exhibited an increased risks of T2D (HR: 3.60, 95% CI 3.39–3.83), stroke (HR: 1.11, 95% CI 1.03–1.19), CHD (HR: 1.52, 95% CI 1.46–1.58), first cardiometabolic disease (FCMD, HR: 1.86, 95% CI 1.81–1.92), CMM (HR: 2.50, 95% CI 2.23–2.80), and death (HR: 1.25, 95% CI 1.20–1.29).”

    Humanshigh vs low CTI groupn = 266,049

    Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study

    Cardiovascular diabetology

  9. C-reactive protein-triglyceride-glucose index is linked with a higher risk of mortality in humans (cancer survivors) (HR 1.54 [1.38-1.71]).

    “all-cause mortality (HR 1.54 [1.38–1.71])”

    Humanscancer survivors

    C-reactive protein-triglyceride-glucose index and its obesity-related derivatives as predictors of cardiovascular incidence and cause-specific mortality among cancer survivors: a prospective cohort study

    Research SquarePreprint

  10. C-reactive protein-triglyceride-glucose index is linked with a higher risk of mortality in individuals with MASLD (HR 1.47, 95% CI 1.28-1.69).

    “and a 47% increased risk of all-cause death (hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.28-1.69) in fully adjusted models.”

    Humansin individuals with MASLD

    Association of the C-reactive protein-triglyceride-glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies

    Cardiovascular diabetology

All 17

Cardiovascular mortality

upin humans10HR 1.32–1.72

10 studies
  1. C-reactive protein-triglyceride-glucose index is associated with cardiovascular mortality in humans (Patients with chronic kidney disease and coronary artery disease; adjusted analysis) (HR 1.32, 95% CI 1.06–1.64).

    “Adjusted models showed elevated composite indices linked to higher mortality (e.g., CTI HR 1.43 [95% CI 1.24–1.65] for all-cause; HR 1.32 [1.06–1.64] for CVD).”

    HumansPatients with chronic kidney disease and coronary artery disease; adjusted analysisMedian follow-up of 63 monthsn = 1,353

    Prognostic stratification with composite insulin resistance inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses

    ESC Congress 2026 abstract

  2. C-reactive protein-triglyceride-glucose index predicts cardiovascular mortality in humans (per SD increase) (40% higher risk (95% CI: 1.20-1.62)).

    “Each SD increase in CTI was associated with a 35% higher risk of all-cause mortality (95% CI: 1.24-1.48) and a 40% higher risk of cardiovascular mortality (95% CI: 1.20-1.62).”

    Humansper SD increase152 months median follow-upn = 8,314

    Association Between C-Reactive Protein-Triglyceride Glucose Index and All-Cause and Cardiovascular Mortality Across Cardiovascular-Kidney-Metabolic Syndrome Stages 0-4

    International journal of endocrinology

  3. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular mortality in individuals with MASLD (HR 1.57, 95% CI 1.24-1.99).

    “Each unit increase in CTI in NHANES was linked to a 57% increased risk of cardiovascular death (HR 1.57, 95% CI 1.24-1.99)”

    Humansin individuals with MASLD

    Association of the C-reactive protein-triglyceride-glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies

    Cardiovascular diabetology

  4. C-reactive protein-triglyceride-glucose index is associated with cardiovascular mortality in humans (metabolic syndrome, quartile 4 vs quartile 1) (HR 1.60, 95% CI 1.13-2.25).

    “However, Quartile 4 had significantly higher CV mortality (HR = 1.60; 95% CI: 1.13-2.25; P = .007).”

    Humansmetabolic syndrome, quartile 4 vs quartile 1n = 10,421

    C-reactive protein-triglyceride-glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome

    Journal of clinical lipidology

  5. C-reactive protein-triglyceride-glucose index predicts cardiovascular mortality in humans (metabolic syndrome) (HR 1.32, 95% CI 1.07-1.62).

    “In a fully adjusted survey-weighted model, each 1-unit increase in CTI was associated with a 32% higher risk of CV mortality (hazard ratio [HR] = 1.32; 95% CI: 1.07-1.62; P = .010).”

    Humansmetabolic syndromen = 10,421

    C-reactive protein-triglyceride-glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome

    Journal of clinical lipidology

  6. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular mortality in humans (highest tertile vs middle tertile) (HR 1.43, 95% CI: 1.16-1.76).

    “Tertile comparisons showed that the highest group/tertile group had significantly increased risks for all-cause (adjusted HR 1.34, 95% CI: 1.19-1.51) and cardiovascular mortality (HR 1.43, 95% CI: 1.16-1.76)”

    Humanshighest tertile vs middle tertilefemalesn = 5,582

    Association of C-reactive protein-triglyceride-glucose index with all-cause and cardiovascular mortality in postmenopausal women

    Przeglad menopauzalny = Menopause review

  7. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular mortality in humans (patients with diabetic foot) (HR = 1.50, 95% CI:1.06-2.11).

    “50% higher CVD mortality (HR = 1.50, 95% CI:1.06-2.11)”

    Humanspatients with diabetic foot47 monthsn = 827

    The association between the C-reactive protein-triglyceride-glucose index and all-cause and cardiovascular mortality in patients with diabetic foot: A retrospective cohort study

    Diabetes research and clinical practice

  8. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular mortality in humans (AUC 0.8208).

    “higher CTI levels were significantly associated with increased risks of all-cause and cardiovascular mortality across all three cohorts after full adjustment.”

    Humansn = 11,619

    Association between C-reactive protein-triglyceride glucose index (CTI) and cardiovascular and all-cause mortality risk among the elderly population: insights from three datasets

    Clinical research in cardiology : official journal of the German Cardiac Society

  9. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular mortality in humans (metabolic syndrome, quartile 4 vs quartile 1) (HR 1.72, 95% CI: 1.30–2.28).

    “patients in quartile 4 had significantly higher CV mortality, with a hazard ratio of 1.72 (95% CI: 1.30–2.28, p<0.001)”

    Humansmetabolic syndrome, quartile 4 vs quartile 1

    The Association between C-Reactive Protein-Triglyceride-Glucose Index and Cardiovascular Mortality in Patients with Metabolic Syndrome

    AHA Scientific Sessions 2025 abstract

  10. C-reactive protein-triglyceride-glucose index predicts cardiovascular mortality in humans (metabolic syndrome) (HR 1.34, 95% CI: 1.15–1.57).

    “each one-unit increase in CTI was associated with a 34% higher CV mortality (HR = 1.34, 95% CI: 1.15–1.57, p<0.001)”

    Humansmetabolic syndrome

    The Association between C-Reactive Protein-Triglyceride-Glucose Index and Cardiovascular Mortality in Patients with Metabolic Syndrome

    AHA Scientific Sessions 2025 abstract

All 12

Cardiometabolic multimorbidity

upin humans9OR 1.45–1.57

9 studies
  1. C-reactive protein-triglyceride-glucose index is associated with cardiometabolic multimorbidity in humans (Chinese adults; fully adjusted model) (OR 1.57 per 1-SD increase, 95% CI 1.49–1.65).

    “After standardization to a per-1-SD increase, CTI showed the strongest association (OR = 1.57, 95% CI: 1.49-1.65), followed by LAP (OR = 1.49) and AIP (OR = 1.44).”

    HumansChinese adults; fully adjusted modelper-1-SD increasen = 10,383

    The interconnections between novel adiposity indices and cardiometabolic multimorbidity in Chinese adults: a population-based cross-sectional study

    BMC cardiovascular disorders

  2. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (highest quartile vs lowest quartile) (HR 2.57, 95% CI 2.00–3.30).

    “participants in the highest quartile of baseline CTI had a 2.57-fold higher risk of CMM compared with those in the lowest quartile (HR 2.57, 95% CI 2.00–3.30).”

    Humanshighest quartile vs lowest quartile

    Association between the changes in the C-reactive protein-triglyceride-glucose index and future cardiometabolic multimorbidity risk: a nationwide cohort study

    Research SquarePreprint

  3. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (Q4 vs Q1) (HR 2.55 (95% CI 1.82-3.57)).

    “2.55 (1.82-3.57) for CTI Q4 versus Q1”

    HumansQ4 vs Q1n = 5,666

    Associations of three metabolic biomarkers with the risk of cardiometabolic multimorbidity: a national prospective study

    Lipids in health and disease

  4. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (MASLD without CMDs at baseline) (HR 1.50 (95% CI 1.45-1.54)).

    “and 1.50 (1.45-1.54) for CTI (all P < 0.001).”

    HumansMASLD without CMDs at baseline16 yearsn = 109,181

    Associations between the C-reactive protein-triglyceride-glucose index and its derived indices and the incidence and progression of cardiometabolic multimorbidity in participants with metabolic dysfunction-associated steatotic liver disease: a large-scale prospective cohort study

    Cardiovascular diabetology

  5. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (HR 1.41, 95% CI 1.17–1.69).

    “a 1‐standard deviation increase in the CTI was associated with a 41% higher CMM risk (hazard ratio [HR]: 1.41, 95% confidence interval [CI]: 1.17–1.69).”

    Humansn = 9,477

    Associations of C‐Reactive Protein–Triglyceride–Glucose Index With the Incidence and Progression of Cardiometabolic Multimorbidity in Middle‐Aged and Older Chinese Individuals: A Prospective Cohort Study From CHARLS

    iLABMED

  6. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (persistent high-risk change cluster (Cluster 2)) (HR = 2.37, 95% CI: 1.73–3.24).

    “Both the moderate growth change cluster (Cluster 1) and the persistent high-risk change cluster (Cluster 2) were associated with significantly elevated CMM risks (HR = 1.89, 95% CI: 1.47–2.44; HR = 2.37, 95% CI: 1.73–3.24, respectively).”

    Humanspersistent high-risk change cluster (Cluster 2)n = 4,461

    Associations of cumulative exposure and dynamic patterns of the C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and elderly Chinese: a nationwide cohort study

    BMC public health

  7. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (high vs low CTI group) (HR: 2.50, 95% CI 2.23–2.80).

    “the high-CTI group exhibited an increased risks of T2D (HR: 3.60, 95% CI 3.39–3.83), stroke (HR: 1.11, 95% CI 1.03–1.19), CHD (HR: 1.52, 95% CI 1.46–1.58), first cardiometabolic disease (FCMD, HR: 1.86, 95% CI 1.81–1.92), CMM (HR: 2.50, 95% CI 2.23–2.80)”

    Humanshigh vs low CTI groupn = 266,049

    Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study

    Cardiovascular diabetology

  8. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (OR 1.45, 95% CI 1.31-1.61).

    “After adjustment, the risk remained elevated by 45 % (OR = 1.45, 95 % CI: 1.31-1.61, p < 0.001).”

    Humans4 yearsn = 15,497

    Dose-response relationship of the C-reactive protein-triglyceride-glucose index with incident cardiometabolic multimorbidity ‒ A cohort study in middle-aged and elderly Chinese adults

    Nutricion hospitalaria

  9. C-reactive protein-triglyceride-glucose index predicts cardiometabolic multimorbidity in humans (adding CTI to traditional risk factors) (0.753 to 0.778).

    “After adding CTI to a model containing traditional risk factors, the area under the receiver operating characteristic curve (AUC) for 4-year CMM prediction increased from 0.753 to 0.778.”

    Humansadding CTI to traditional risk factors4-year

    The association of C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies

    Cardiovascular diabetology

  10. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiometabolic multimorbidity in humans (HR = 1.71, 95% CI 1.39-2.11).

    “In the primary model, each 1-unit increase in baseline CTI was associated with a 71% higher risk of CMM (HR = 1.71, 95% CI 1.39-2.11)”

    Humansapproximately 9 years

    The association of C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies

    Cardiovascular diabetology

More on Cardiometabolic multimorbidity

Stroke

upin humans8HR 1.11–1.92

8 studies
  1. C-reactive protein-triglyceride-glucose index is linked with a higher risk of stroke in individuals with hypertension (HR 1.14, 95% CI 1.07 to 1.21).

    “stroke (HR, 1.14; 95% CI, 1.07 to 1.21)”

    Humansin individuals with hypertension

    The C-Reactive Protein-Triglyceride Glucose Index and Incidence of Cardiovascular Disease Among Individuals with Hypertension: A Nationwide Prospective Cohort Study

    Endocrinology and metabolism (Seoul, Korea)

  2. C-reactive protein-triglyceride-glucose index is linked with a higher risk of stroke in humans (mild cognitive impairment) (OR 1.34, 95% CI 1.04-1.72).

    “each one-unit increase in CTI was associated with a 34% higher risk of stroke among MCI patients (Odds Ratio (OR): 1.34, 95% Confidence Interval (CI): 1.04-1.72, p < 0.05)”

    Humansmild cognitive impairment

    Multifactorial stratified analysis of two novel metabolism-related indices for predicting stroke in mild cognitive impairment

    Frontiers in neurology

  3. C-reactive protein-triglyceride-glucose index is linked with a higher risk of stroke in humans (highest tertile versus lowest in individuals at CKM stages 0-3) (HR 1.92, 95% CI 1.35-2.73).

    “participants in the highest tertile of all CTI-related indices had significantly increased stroke risk, with hazard ratios (HRs) ranging from 1.92 (95%CI 1.35-2.73) for original CTI”

    Humanshighest tertile versus lowest in individuals at CKM stages 0-3n = 3,348

    Association of C-reactive protein-triglyceride glucose index and its modified indices with stroke risk in individuals at cardiovascular-kidney-metabolic syndrome stages 0-3: a population-based cohort study

    Cardiovascular diabetology

  4. C-reactive protein-triglyceride-glucose index is linked with a higher risk of stroke in humans (high vs low CTI group) (HR: 1.11, 95% CI 1.03–1.19).

    “the high-CTI group exhibited an increased risks of T2D (HR: 3.60, 95% CI 3.39–3.83), stroke (HR: 1.11, 95% CI 1.03–1.19)”

    Humanshigh vs low CTI groupn = 266,049

    Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study

    Cardiovascular diabetology

  5. C-reactive protein-triglyceride-glucose index is linked with a higher risk of stroke in humans (HR 1.15, 95% CI 1.00-1.32).

    “each 1-unit increase in CTI was associated with a 15% higher stroke risk [hazard ratios (HR) = 1.15, 95% confidence interval (CI) = 1.00-1.32]”

    Humans7 yearsn = 8,808

    Association between C-reactive protein-triglyceride-glucose index and risk of stroke in different renal function status: a national cohort study

    Cardiovascular diabetology

  6. C-reactive protein-triglyceride-glucose index is associated with stroke in humans (OR 1.676, 95% CI 1.491–1.883; p-nonlinear = 0.012).

    “stroke (OR = 1.676, 95% CI: 1.491, 1.883)”

    Humans2011–2020n = 9,275

    The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study

    Brain and behavior

  7. C-reactive protein-triglyceride-glucose index is linked with a higher risk of stroke in humans (high CTI levels showing a slow increasing trend) (HR 1.75, 95% CI 1.25-2.48).

    “and those with high CTI levels showing a slow increasing trend (HR = 1.75, 95% CI: 1.25-2.48, P < 0.001) had a significantly higher risk of stroke.”

    Humanshigh CTI levels showing a slow increasing trendn = 4,364

    Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident stroke in middle-aged and older Chinese adults: a longitudinal analysis based on CHARLS

    Cardiovascular diabetology

  8. C-reactive protein-triglyceride-glucose index is linked with a higher risk of stroke in humans (free of diabetes) (HR 1.76, 95% CI 1.34-2.30).

    “Compared to the stable low group, a significant higher risk of stroke was only observed in the stable high group (hazard ratio [HR], 1.76; 95 % confidence interval [CI], 1.34-2.30)”

    Humansfree of diabetesmedian follow-up of 3.50 yearsn = 5,973

    Change in C-reactive protein-triglyceride glucose index and risk of stroke among middle-aged and older adults free of diabetes: A national cohort study

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Stroke

Cardiovascular disease

upin humans6OR 1.18–1.194

6 studies
  1. C-reactive protein-triglyceride-glucose index is associated with cardiovascular disease in humans (fully adjusted overall population) (OR 1.194, 95% CI 1.112–1.282).

    “each 1-unit increase in CTI was associated with prevalent CVD (OR 1.194, 95% CI 1.112–1.282; P <0.001)”

    Humansfully adjusted overall population

    C-Reactive Protein–Triglyceride-Glucose Index and Incident Cardiovascular Disease Stratified by Antihypertensive Medication Use: Evidence from CHARLS

    Research SquarePreprint

  2. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (fully adjusted overall population) (HR 1.096, 95% CI 1.024–1.174).

    “each 1-unit increase in CTI was associated with prevalent CVD (OR 1.194, 95% CI 1.112–1.282; P <0.001) and incident CVD (HR 1.096, 95% CI 1.024–1.174; P =0.008)”

    Humansfully adjusted overall population

    C-Reactive Protein–Triglyceride-Glucose Index and Incident Cardiovascular Disease Stratified by Antihypertensive Medication Use: Evidence from CHARLS

    Research SquarePreprint

  3. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (rectal cancer survivors, discovery cohort) (OR = 1.18, 95% CI: 1.02-1.36).

    “each one-SD increment in CTI was associated with an 18% higher risk of incident CVD (OR = 1.18, 95% CI: 1.02-1.36, p = 0.025)”

    Humansrectal cancer survivors, discovery cohort

    Association of the C-reactive protein-triglyceride-glucose index with the risk of incident cardiovascular disease in rectal cancer survivors

    Frontiers in cardiovascular medicine

  4. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular disease in adults with arthritis (HR 1.251, 95% CI 1.083-1.446).

    “baseline CTI was associated with incident CVD [hazard ratio (HR) = 1.251, 95% confidence interval (CI): 1.083-1.446, p = 0.002]”

    Humansin adults with arthritisn = 2,894

    Association between the C-reactive protein-triglyceride-glucose index and incident cardiovascular disease in middle-aged and older adults with arthritis: a nationwide prospective cohort study with hospital-based cross-sectional replication

    Frontiers in immunology

  5. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (adjusted for demographic and clinical confounders).

    “CTI and its modified indices all maintained robust, independent associations with incident CVD.”

    Humansadjusted for demographic and clinical confounders

    Association of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose and its modified indices with cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS

    Cardiovascular diabetology

  6. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (cancer survivors) (HR 1.65 [1.44-1.89]).

    “high CTI-related indices were significantly and positively associated with incident CVD events (HR 1.65 [1.44–1.89])”

    Humanscancer survivors

    C-reactive protein-triglyceride-glucose index and its obesity-related derivatives as predictors of cardiovascular incidence and cause-specific mortality among cancer survivors: a prospective cohort study

    Research SquarePreprint

  7. C-reactive protein-triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (prospective cohort) (HR up to 1.58).

    “Higher CTI quartiles (Q3/Q4) were associated with a significantly elevated risk of CVD, particularly among males (hazard ratio [HR] up to 1.58) and middle-aged individuals (HR 1.57).”

    Humansprospective cohortmedian follow-up period of 108.1 monthsn = 7,584

    Link between C-reactive protein-triglyceride glucose index and cardiovascular disease risk in diverse glycemic statuses: insights from the CHARLS

    medRxivPreprint

More on Cardiovascular disease

Sarcopenia

downin humans1upin humans1OR 0.732–1.52

2 studies
  1. C-reactive protein-triglyceride-glucose index is associated with sarcopenia in humans (Fully adjusted analysis in Chinese adults) (Fully adjusted OR 0.732, 95% CI 0.615–0.869).

    “Higher CTI levels were found to be inversely correlated with sarcopenia risk,”

    HumansFully adjusted analysis in Chinese adults4 yearsboth; 53.9% femalesn = 5,741

    Association between the C-reactive protein-triglyceride glucose index and incident sarcopenia in middle-aged and elderly Chinese: A prospective nationwide cohort study in China

    Experimental gerontology

  2. C-reactive protein-triglyceride-glucose index predicts sarcopenia in humans (AUC: 0.730 (CHARLS), 0.722 (NHANES)).

    “compared to CRP and the TyG index, CTI exhibited the best predictive capability for sarcopenia risk, with the highest AUC (CHARLS: 0.730, NHANES: 0.722)”

    Humans

    Association between C-reactive protein-triglyceride glucose index and risk of sarcopenia in older adults: findings from CHARLS and NHANES

    Experimental gerontology

  3. C-reactive protein-triglyceride-glucose index is linked with a higher risk of sarcopenia in humans (OR: 1.52, 95 %CI: 1.15-1.99, P = 0.004).

    “revealed the cross-sectional (OR: 1.52, 95 %CI: 1.15-1.99, P = 0.004) and longitudinal (HR: 1.35, 95 %CI: 1.10-1.65, P = 0.004) correlation between CTI and sarcopenia risk”

    Humans

    Association between C-reactive protein-triglyceride glucose index and risk of sarcopenia in older adults: findings from CHARLS and NHANES

    Experimental gerontology

More on Sarcopenia

Incident sarcopenia

downin humans1mixedin humans1OR 0.89

2 studies
  1. C-reactive protein-triglyceride-glucose index is associated with incident sarcopenia in humans (Chinese participants without sarcopenia at baseline) (Adjusted OR 0.89 per unit increase, 95% CI 0.79–0.98; highest versus lowest quartile OR 0.71, 95% CI 0.55–0.92).

    “A higher baseline C-reactive protein–triglyceride–glucose index was associated with lower odds of incident sarcopenia”

    HumansChinese participants without sarcopenia at baseline4 years

    Association of the C-reactive protein–triglyceride–glucose index with incident sarcopenia in Chinese middle-aged and older adults: A prospective cohort study

    The Journal of international medical research

  2. C-reactive protein-triglyceride-glucose index predicts incident sarcopenia in humans (Prediction analysis in Chinese adults; model composition not specified) (ROC AUC 0.831).

    “The area under the ROC curve for prediction was 0.831.”

    HumansPrediction analysis in Chinese adults; model composition not specified4 yearsboth; 53.9% femalesn = 5,741

    Association between the C-reactive protein-triglyceride glucose index and incident sarcopenia in middle-aged and elderly Chinese: A prospective nationwide cohort study in China

    Experimental gerontology

More on Incident sarcopenia

Chronic kidney disease

upin humans2OR 1.26–1.32

2 studies
  1. C-reactive protein-triglyceride-glucose index is associated with chronic kidney disease in humans (adjusted for confounding variables) (OR 1.32, 95% CI 1.25–1.38).

    “Logistic regression analysis revealed a positive association between CTI and CKD, even after adjusting for the confounding variables”

    Humansadjusted for confounding variablesn = 12,396

    Association between a C-Reactive Protein-Triglyceride Glucose Index and Chronic Kidney Disease in US Adults

    Clinical laboratory

  2. C-reactive protein-triglyceride-glucose index is linked with a higher risk of chronic kidney disease in humans (OR = 1.26, 95% CI: 1.08, 1.47; P = .003).

    “there was a positive association of CTI with the incidence of new-onset CKD (OR = 1.26, 95% CI: 1.08, 1.47; P = .003)”

    Humansn = 3,435

    Association of C-Reactive Protein-Triglyceride Glucose Index With Chronic Kidney Disease and Reduction of Renal Function

    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

More on Chronic kidney disease

Incident stroke

upin humans2OR 2.054

2 studies
  1. C-reactive protein-triglyceride-glucose index is associated with incident stroke in humans (Highest versus lowest quartile; fully adjusted model) (Q4 versus Q1: OR 2.054, 95% CI 1.546–2.729).

    “participants in the highest quartile of CTI (Q4) had a significantly higher risk compared to those in the lowest quartile (Q1)”

    HumansHighest versus lowest quartile; fully adjusted model7 yearsn = 7,365

    Association between metabolic-inflammatory indices and new-onset stroke: A longitudinal study based on CHARLS

    Medicine

  2. C-reactive protein-triglyceride-glucose index is associated with incident stroke in humans (High CTI; fully adjusted model; participants without baseline stroke) (HR 1.62, 95% CI 1.35–1.95).

    “high CTI and high FI were independently associated with increased stroke risk”

    HumansHigh CTI; fully adjusted model; participants without baseline stroken = 8,755

    Joint association of the C-reactive protein-triglyceride-glucose index and frailty with incident stroke: a nationwide prospective cohort study

    BMC public health

More on Incident stroke

Frailty

upin humans2HR 1.24–1.35

2 studies
  1. C-reactive protein-triglyceride-glucose index is linked with a higher risk of frailty in humans (compared with the low trajectory) (HR 1.24, 95% CI 1.03-1.49).

    “the high trajectory was independently associated with augmented incident frailty risk (Chinese cohort: hazard ratio 1.24, 95% confidence interval 1.03-1.49”

    Humanscompared with the low trajectoryn = 3,947

    High metabolic inflammation trajectories predict faster frailty progression in older adults

    Maturitas

  2. C-reactive protein-triglyceride-glucose index is linked with a higher risk of frailty in humans (HR 1.35, 95% CI 1.21-1.50).

    “each unit increment in the baseline CTI was associated with a 35% escalation in the likelihood of frailty (HR, 1.35; 95% CI, 1.21-1.50).”

    Humansn = 5,366

    Association between different dimensions of C-reactive protein-triglyceride-glucose index and the incidence of frailty in middle-aged and elderly adults in China: a nationwide prospective cohort study

    Lipids in health and disease

All 45

Latest

Dec 2025: 1Jan 2026: 9Feb 2026: 9Mar 2026: 11Apr 2026: 5May 2026: 4Jun 2026: 9Jul 2026: 7Aug 2026: 9Sep 2026: 8Oct 2026: 15Nov 2026: 794 papers in 12 months
Research Square

Blood and body-size scores linked to cardiovascular risk

In 5,304 Chinese adults, one score was linked to new cardiovascular disease with a hazard ratio of 1.213 per standard-deviation increase.In 5,304 Chinese adults, one score was linked to new cardiovascular disease with a hazard ratio of 1.213 per standard-deviation increase.

Preprint: cohort · 5,304 peopleCardiovascular disease
Healthcare

Blood and frailty score linked to multiple chronic conditions

Relative rates of developing multiple conditions were 3.40 in China and 2.62 in England for the highest-scoring quarter versus the lowest.Relative rates of developing multiple conditions were 3.40 in China and 2.62 in England for the highest-scoring quarter versus the lowest.

Cohort · 7,108 peopleBiomarkers

See all 102 papers on C-reactive protein-triglyceride-glucose index